Cerium dioxide nanoparticles do not modulate the lipopolysaccharide-induced inflammatory response in human monocytes. 2012

Salik Hussain, and Faris Al-Nsour, and Annette B Rice, and Jamie Marshburn, and Zhaoxia Ji, and Jeffery I Zink, and Brenda Yingling, and Nigel J Walker, and Stavros Garantziotis
Clinical Research Unit, National Institute of Environmental Health Sciences/National Institute of Health, Research Triangle Park, Durham, NC 27709, USA. salik.hussain@nih.gov

BACKGROUND Cerium dioxide (CeO(2)) nanoparticles have potential therapeutic applications and are widely used for industrial purposes. However, the effects of these nanoparticles on primary human cells are largely unknown. The ability of nanoparticles to exacerbate pre-existing inflammatory disorders is not well documented for engineered nanoparticles, and is certainly lacking for CeO(2) nanoparticles. We investigated the inflammation-modulating effects of CeO(2) nanoparticles at noncytotoxic concentrations in human peripheral blood monocytes. METHODS CD14(+) cells were isolated from peripheral blood samples of human volunteers. Cells were exposed to either 0.5 or 1 μg/mL of CeO(2) nanoparticles over a period of 24 or 48 hours with or without lipopolysaccharide (10 ng/mL) prestimulation. Modulation of the inflammatory response was studied by measuring secreted tumor necrosis factor-alpha, interleukin-1beta, macrophage chemotactic protein-1, interferon-gamma, and interferon gamma-induced protein 10. RESULTS CeO(2) nanoparticle suspensions were thoroughly characterized using dynamic light scattering analysis (194 nm hydrodynamic diameter), zeta potential analysis (-14 mV), and transmission electron microscopy (irregular-shaped particles). Transmission electron microscopy of CD14(+) cells exposed to CeO(2) nanoparticles revealed that these nanoparticles were efficiently internalized by monocytes and were found either in vesicles or free in the cytoplasm. However, no significant differences in secreted cytokine profiles were observed between CeO(2) nanoparticle-treated cells and control cells at noncytotoxic doses. No significant effects of CeO(2) nanoparticle exposure subsequent to lipopolysaccharide priming was observed on cytokine secretion. Moreover, no significant difference in lipopolysaccharide-induced cytokine production was observed after exposure to CeO(2) nanoparticles followed by lipopolysaccharide exposure. CONCLUSIONS CeO(2) nanoparticles at noncytotoxic concentrations neither modulate pre-existing inflammation nor prime for subsequent exposure to lipopolysaccharides in human monocytes from healthy subjects.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002563 Cerium An element of the rare earth family of metals. It has the atomic symbol Ce, atomic number 58, and atomic weight 140.12. Cerium is a malleable metal used in industrial applications.
D006651 Histocytochemistry Study of intracellular distribution of chemicals, reaction sites, enzymes, etc., by means of staining reactions, radioactive isotope uptake, selective metal distribution in electron microscopy, or other methods. Cytochemistry
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses

Related Publications

Salik Hussain, and Faris Al-Nsour, and Annette B Rice, and Jamie Marshburn, and Zhaoxia Ji, and Jeffery I Zink, and Brenda Yingling, and Nigel J Walker, and Stavros Garantziotis
January 2016, International journal of nanomedicine,
Salik Hussain, and Faris Al-Nsour, and Annette B Rice, and Jamie Marshburn, and Zhaoxia Ji, and Jeffery I Zink, and Brenda Yingling, and Nigel J Walker, and Stavros Garantziotis
November 2022, Free radical biology & medicine,
Salik Hussain, and Faris Al-Nsour, and Annette B Rice, and Jamie Marshburn, and Zhaoxia Ji, and Jeffery I Zink, and Brenda Yingling, and Nigel J Walker, and Stavros Garantziotis
January 2013, Autophagy,
Salik Hussain, and Faris Al-Nsour, and Annette B Rice, and Jamie Marshburn, and Zhaoxia Ji, and Jeffery I Zink, and Brenda Yingling, and Nigel J Walker, and Stavros Garantziotis
October 1994, Scandinavian journal of clinical and laboratory investigation,
Salik Hussain, and Faris Al-Nsour, and Annette B Rice, and Jamie Marshburn, and Zhaoxia Ji, and Jeffery I Zink, and Brenda Yingling, and Nigel J Walker, and Stavros Garantziotis
January 2005, Journal of endotoxin research,
Salik Hussain, and Faris Al-Nsour, and Annette B Rice, and Jamie Marshburn, and Zhaoxia Ji, and Jeffery I Zink, and Brenda Yingling, and Nigel J Walker, and Stavros Garantziotis
June 2014, Nature communications,
Salik Hussain, and Faris Al-Nsour, and Annette B Rice, and Jamie Marshburn, and Zhaoxia Ji, and Jeffery I Zink, and Brenda Yingling, and Nigel J Walker, and Stavros Garantziotis
April 2015, Nature communications,
Salik Hussain, and Faris Al-Nsour, and Annette B Rice, and Jamie Marshburn, and Zhaoxia Ji, and Jeffery I Zink, and Brenda Yingling, and Nigel J Walker, and Stavros Garantziotis
January 2020, Cells,
Salik Hussain, and Faris Al-Nsour, and Annette B Rice, and Jamie Marshburn, and Zhaoxia Ji, and Jeffery I Zink, and Brenda Yingling, and Nigel J Walker, and Stavros Garantziotis
May 2008, Metabolism: clinical and experimental,
Salik Hussain, and Faris Al-Nsour, and Annette B Rice, and Jamie Marshburn, and Zhaoxia Ji, and Jeffery I Zink, and Brenda Yingling, and Nigel J Walker, and Stavros Garantziotis
August 2020, Journal of biomedical materials research. Part A,
Copied contents to your clipboard!